Drugs and Biologicals, Coverage of, for Label and Off-Label Uses
J6 · Effective Oct 1, 2015
9 active Medicare policies list J7322, and 7 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JJ · Effective Aug 21, 2022
JM · Effective Aug 21, 2022
J5 · Effective Jun 11, 2023
J8 · Effective Jun 11, 2023
J6 · Effective Apr 1, 2026
National · Effective Jan 1, 2026
J5 · Effective Jun 25, 2026
7 policies from 7 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J7322 |
|---|---|---|
| Viscosupplementation | Jan 1, 2024 | Covered |
| Policy | Effective | Status of J7322 |
|---|---|---|
| Hyaluronic Acid Derivatives: Durolane, Euflexxa, Gel-One, GelSyn-3, GenVisc 850, Hyalgan, Hymovis, Hymovis One, Monovisc, Orthovisc, Supartz FX, Synojoynt, Synvisc, & Synvisc-One, Triluron, TriVisc, VISCO-3 | Apr 30, 2026 | Covered with conditionsInferred from policy title |
| Policy | Effective | Status of J7322 |
|---|---|---|
| Hyaluronic Acid Derivatives: Durolane, Euflexxa, Gel-One, GelSyn-3, GenVisc 850, Hyalgan, Hymovis, Monovisc, Orthovisc, Supartz/Supartz FX, Synojoynt, Synvisc, Synvisc-One, Triluron, TriVisc, VISCO-3, & sodium hyaluronate 1% | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7322 |
|---|---|---|
| Sodium Hyaluronate | Oct 1, 2026 | Covered |
| Policy | Effective | Status of J7322 |
|---|---|---|
| Sodium Hyaluronate | Oct 1, 2026 | Covered |
| Policy | Effective | Status of J7322 |
|---|---|---|
| Sodium Hyaluronate | Oct 1, 2026 | Covered |
| Policy | Effective | Status of J7322 |
|---|---|---|
| Treatment of Temporomandibular Joint (TMJ) | Not recorded | Covered |